Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1995
10/12/1995WO1995026754A1 Segmented chelating polymers as imaging and therapeutic agents
10/12/1995WO1995026752A1 Product for the enteric supply of food components and process for making it
10/12/1995WO1995026750A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995WO1995026715A2 Use of fatty acid esters as bioadhesive substances
10/12/1995WO1995026713A1 Heterofunctional, mucoadhesive dosage form
10/12/1995WO1995026712A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995WO1995026711A1 Ophthalmic composition with decreased viscosity
10/12/1995WO1995026709A1 Topical retinal-based composition
10/12/1995WO1995024928A3 Heparin-binding growth factors for gene therapy and anterior eye disorders
10/12/1995WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
10/12/1995WO1995022991A3 Block copolymers
10/12/1995CA2186863A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2186861A1 Biological markers of benign prostate hyperplasia
10/12/1995CA2186734A1 Ophthalmic composition with decreased viscosity
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995CA2185812A1 Segmented chelating polymers as imaging and therapeutic agents
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676195A1 Cosmetic composition for skin cleansing mask containing polyamide particles of a determined size
10/11/1995EP0676187A2 Composition containing a non photocatalytic metal oxide and tocopherol, its cosmetic and/or dermatologic use and methods for its preparation
10/11/1995EP0675737A1 Immunoreactive reagents employing dihydrofolate reductase
10/11/1995EP0675736A1 Improved synthesis of polymer bio-active conjugates
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0675727A1 Glycolipid enzyme-polymer conjugates
10/11/1995EP0675711A1 Atovaquone pharmaceutical compositions
10/11/1995EP0559682B1 Topical composition
10/11/1995CN1109891A Methods for preventing degradation of protein C
10/11/1995CN1109886A Method for preparing thioether conjugates
10/11/1995CN1109785A Organopolysiloxane composition of gel-like apperarance, containing no gelling agent, which may be used in cosmetics and dermatology
10/11/1995CN1109756A Calcium-modified oxidized cellulose hemostat
10/11/1995CN1109754A Argatroban consentrated aqueous solution
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/11/1995CN1109748A Rapamycin formulation for IV injection
10/11/1995CN1109747A Rapamycin formulation for IV injection
10/11/1995CN1109746A Rapamycin formulations for oral administration
10/11/1995CN1109745A Ibuprofen-containing solid composition
10/11/1995CN1109743A Controlled release-initiation and controlled release-rate pharmaceutical composition
10/11/1995CN1109741A Cosmatic and/or dermal composition containing salicylic acid
10/10/1995US5457195 Sapphyrin derivatives and conjugates
10/10/1995US5457191 3-deazapurines
10/10/1995US5457183 Radiosensitizers
10/10/1995US5457093 Gel formulations containing growth factors
10/10/1995US5456932 Adding fructose to reduce heat needed to create flash flow conditions
10/10/1995US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution
10/10/1995US5456922 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995US5456908 Inhibiting cellular uptake of polyamines by contacting cells with transport inhibitory amount of polymer or copolymer of said polyamines
10/10/1995US5456901 Administering liposome having encapsulated contrast enhancing agent, scanning patient using ultrasonic imaging
10/10/1995US5456663 Drugs and methods for treating diseases
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/10/1995CA1337275C Aqueous based pharmaceutical coating composition for dosage forms
10/10/1995CA1337272C Drug adsorbates
10/10/1995CA1337270C Multilayer plaster
10/10/1995CA1337262C Time release protein
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis
10/05/1995WO1995026192A1 Starch-metal complexes for skin and hair
10/05/1995WO1995026191A1 Injectable solutions of dirithromycin
10/05/1995DE4411402A1 DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen DNA expression vectors for use in gene therapy of vascular diseases
10/05/1995CA2186448A1 Starch-metal complexes for skin and hair
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0674907A2 Conjugabes of a antibody and a carrier protein, useful for active immunotherapy
10/04/1995EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen
10/04/1995EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen
10/04/1995EP0674734A1 Runway-maintenance device.
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674531A1 Process for preparing a virus-safe biological composition
10/04/1995EP0674529A1 Lipid prodrugs for oral administration
10/04/1995EP0674528A1 Cyclodextrin and polymer based drug delivery system
10/04/1995EP0674525A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life
10/04/1995EP0674524A1 Stable lyophilized pharmaceutical preparations g-csf
10/04/1995EP0674522A1 Linseed mucilage
10/04/1995EP0674510A1 Injectable composition
10/04/1995EP0674507A1 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
10/04/1995EP0674506A1 Controlled release growth hormone containing microspheres
10/04/1995EP0674505A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
10/04/1995EP0592446B1 Loading technique for preparing drug containing liposomes
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
10/04/1995CN1109364A Insulin formulation
10/04/1995CN1109328A Sustained release formulations for 24 hour release of metoprolol
10/04/1995CN1109289A Method for making selenium garlic capsule
10/03/1995US5455335 Glycosylated steroids
10/03/1995US5455286 Bioactive composition
10/03/1995US5455270 Stabilized solutions of platinum(II) antitumor agents
10/03/1995US5455236 Stable aqueous compositions
10/03/1995US5455168 α-glycosyl trehalose-forming enzyme
10/03/1995US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin
10/03/1995US5455046 Includes a heteropolysaccharide gum and a homopolysaccharide gum capable of crosslinking
10/03/1995US5455045 High dose formulations
10/03/1995US5455042 Ointment comprising a homogenous mixture of a polymer or copolymer of N-vinylacetamide, water and/or alcohols, and a pharmacologically active component
10/03/1995US5455037 Erythromycin cream
10/03/1995US5455032 Use of phosphocholine hapten conjugates in vaccines
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995US5455027 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
09/1995
09/29/1995CA2145584A1 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen